Dostarlimab-Gxly 500 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 500 mg
Reference Brands: Jemperli(USA/EU)
Category: Oncology Cancer Care
Dostarlimab is a humanized monoclonal antibody that targets PD‑1 on T cells, blocking its interaction with PD‑L1/PD-L2. This releases the “brake” on the immune system, allowing T cells to attack cancer cells. It is used mainly for mismatch repair–deficient (dMMR) endometrial cancer and certain other solid tumors with dMMR.
Dostarlimab-Gxly — third party manufacturing & bulk supply
Dostarlimab-Gxly 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Dostarlimab-Gxly listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dostarlimab-Gxly →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dostarlimab-gxly is used for the treatment of certain advanced or recurrent endometrial cancers that are mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H). It helps the immune system recognize and attack cancer cells by blocking the PD-1 receptor.
It is made from a monoclonal antibody that selectively binds to the programmed death-1 (PD-1) receptor on T-cells, preventing tumor cells from evading immune detection.
The trade name is Jemperli.
Jemperli is manufactured by GlaxoSmithKline (GSK).
The generic name is Dostarlimab-gxly.
The brand name is Jemperli.
It is manufactured by GlaxoSmithKline in its approved biologics production facilities for global distribution.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
